Upcoming approval for weekly insulin
The Ministry of Health is approaching approval of a new weekly insulin for diabetic patients. It is the world's first basal insulin administered once a week instead of daily injections, aiming to improve patient adherence and reduce the psychological and physical burden associated with treatment. The product aims to decrease the number of injections from 365 to 52 annually, while adhering to safety and efficacy standards. It has reached the final stages of registration, with approvals from global health authorities such as the U.S. Food and Drug Administration. This therapy is expected to enhance the quality of life for both Type 1 and Type 2 diabetic patients.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)